Jane Street Group, LLC Affimed N.V. Transaction History

Jane Street Group, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.32 - $0.62 $23,359 - $45,258	-72,998 Reduced 56.24%	56,809 $35,000
Q3 2023 Nov 14, 2023	SELL	$0.46 - $0.65 $113,162 - $159,903	-246,005 Reduced 65.46%	129,807 $62,000
Q2 2023 Aug 14, 2023	BUY	$0.57 - $1.08 $214,212 - $405,876	375,812 New	375,812 $225,000
Q4 2022 Feb 14, 2023	SELL	$1.1 - $2.45 $74,103 - $165,049	-67,367 Reduced 77.27%	19,821 $24,000
Q3 2022 Nov 14, 2022	BUY	$1.96 - $3.32 $31,330 - $53,070	15,985 Added 22.45%	87,188 $179,000
Q2 2022 Aug 16, 2022	SELL	$2.27 - $4.86 $22,053 - $47,214	-9,715 Reduced 12.01%	71,203 $197,000
Q4 2021 Feb 15, 2022	BUY	$5.37 - $7.07 $117,028 - $154,076	21,793 Added 36.86%	80,918 $447,000
Q2 2021 Aug 16, 2021	BUY	$7.78 - $11.4 $126,860 - $185,888	16,306 Added 38.08%	59,125 $502,000
Q1 2021 May 18, 2021	BUY	$5.12 - $8.48 $118,584 - $196,405	23,161 Added 117.82%	42,819 $339,000
Q4 2020 Feb 17, 2021	BUY	$3.16 - $7.03 $62,119 - $138,195	19,658 New	19,658 $114,000
Q2 2020 Aug 17, 2020	SELL	$1.58 - $4.63 $67,281 - $197,159	-42,583 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.44 - $3.02 $61,319 - $128,600	42,583 New	42,583 $67,000
Q3 2019 Nov 14, 2019	SELL	$2.67 - $3.65 $432,844 - $591,716	-162,114 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$2.6 - $4.21 $376,753 - $610,050	144,905 Added 842.03%	162,114 $465,000
Q1 2019 May 16, 2019	BUY	$3.05 - $4.34 $52,487 - $74,687	17,209 New	17,209 $72,000

1.09M

Ticker AFMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,339,008
Market Cap $185M
Description
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.